A Study of Norepinephrine in Patients With Congenital Insensitivity to Pain and Anhidrosis

NCT02624310 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

HSAN Type IV

Interventions

DRUG: Droxidopa (L-DOPS)
DRUG: Placebo

Sponsor

NYU Langone Health